17 State Street
New York, NY 10004
917 267 0216
Secteur(s): Financial Services
Secteur d’activité: Shell Companies
Employés à temps plein:
|Nom||Titre||Payer||Exercé||Année de naissance|
|Mr. Jonas Sven Magnus Grossman M.B.A.||Exec. Chairman||S.O.||S.O.||1975|
|Mr. Murat Omur||Chief Exec. Officer||S.O.||S.O.||1978|
|Mr. Sean McGann||Chief Financial Officer||S.O.||S.O.||1986|
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
L’ISS Governance QualityScore de Monterey Bio Acquisition Corporation en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..